SEC EDGARSEP 101 min read$LRCX

Mayer Bethany sold $3.0M of LRCX (indirect holdings)

Mayer Bethany sold 9,557 indirectly-held shares of LAM RESEARCH CORP (LRCX) at $314.74 ($3.01M total) on 2026-09-09.

Original reporting

SEC EDGAR · Mayer Bethany

Published Sep 10, 2026, 5:04 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 10, 2026, 5:05 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefInsider activity

Primary signal

$LRCX

Neutral

medium confidence

Mentioned

$LRCX

Relevance

6/10

AlphAI data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$LRCXNeutralLow

Why it matters

The sale is a routine liquidity move with limited price impact.

Market read

Insider sale of modest size; unlikely to drive significant market moves.

What to watch

Potential upcoming product announcements or earnings that could offset the sale impact.

Relevance 6/10Novelty 4/10Timing: Filed after market close on 2026‑09‑09

Background

Form 4 filings disclose insider transactions; this is the first public report of this sale.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$LRCXNeutralMedium confidence

Context

Director Bethany Mayer sold 9,557 shares for $3.0M in a Form 4 filing, reducing her stake to 20,995 shares.

Expected impact

Potential short‑term dip of 0.5‑1% if market reacts to the sale.

Evidence & confidence

Sale amount is under $5M and represents a small percentage of total holdings; directors often sell for diversification.

Market effects

Sector

Minimal impact on semiconductor sector; insider sales are routine.

Regional

No regional effect beyond U.S. markets.

Global

Limited global relevance.

Counterpoint

What could challenge this read

If the director is cashing out ahead of a potential upside, the stock could rebound.

Key entities

Company
Lam Research Corp.
Semiconductor equipment manufacturer (ticker LRCX).
Individual
Bethany Mayer
Director of Lam Research who sold shares.

Read at source ← All news

OCT 13

$BACMed

US Futures Hold Steady Ahead of Inflation Report

US stock futures were stable on Wednesday ahead of the September inflation report. Bank of America shares fell over 2% after $1.2B in penalties from regulators. Memory stocks declined due to AI investment concerns and Chinese competition, with Micron down 4.6%. Financial stocks also dropped post-earnings, including Citigroup (-5.3%) and Wells Fargo (-2.6%).

tradingview.com2 min

OCT 13

$AMATMed

Applied Materials shares slide as chip equipment outlook remains uncertain

Applied Materials (AMAT) shares dropped 7.5% after it declined to provide a wafer fabrication equipment (WFE) spending forecast, citing uncertainties. CEO Gary Dickerson expressed long-term confidence in AI-driven demand but highlighted near-term variables. Semiconductor equipment peers KLA Corp., Lam Research, and ASML Holding also fell. ASML's upcoming earnings are in focus.

investing.com4 min

OCT 9

$LRCXHigh

Wells Fargo Adjusts Price Target on Lam Research to $355 From $350

Wells Fargo raised its price target for Lam Research (LRCX) to $355 from $350. Morgan Stanley also adjusted its target to $385 from $367, maintaining an overweight rating. LRCX shares closed at $320.59, down 2.71%.

marketscreener.com1 min

OCT 9

$LRCXLow

Round Design Infringement Case Against Lam Research < Supply Chain < 기사본문

BCNC, a South Korean semiconductor component maker, was ordered by a Seoul court to stop producing and distributing certain edge-ring products, pay damages, and destroy existing inventory, following a design-right infringement lawsuit by Lam Research. The court partially dismissed Lam Research's claims. Both companies are also involved in separate patent disputes, with mixed rulings. BCNC plans to appeal the decision.

thelec.net2 min

OCT 8

$LRCXMedAI 8/10

Lam Research Stocks Fall 2.1% as AI Spending Lifts Target 33%

Lam Research (LRCX) shares fell 2.42% to $325.81 on October 7, despite Cantor Fitzgerald raising its price target to $425 from $320. The company reported June-quarter revenue of $6.72 billion, up 15.1% from the prior quarter, with improved margins. Cantor's target suggests 30.4% upside, but shares are 106.68% above GF Value™ estimate of $157.64.

gurufocus.com2 min

OCT 6